NanoCarrier Co., Ltd. - Product Pipeline Review - 2014 (1)

1
NanoCarrier Co., Ltd. - Product Pipeline Review
- 2014
One-Stop Shop for Business Information
2
Summary
NanoCarrier Co., Ltd. - Product Pipeline Review
- 2014, provides an overview of the NanoCarrier
Co., Ltd.s pharmaceutical research and
development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of NanoCarrier
Co., Ltd.s, complete with comparative analysis
at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. It also
reviews latest updates, and featured news and
press releases, along with special features on
late-stage and discontinued projects.
3
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis.
4
Increasing demand for urban housing will drive
residential building construction spending and
related drywall sales. In addition, advances in
office and commercial construction activity will
contribute to demand gains. Going forward,
drywall demand will benefit from local
construction companies increasing drywall usage
at the expense of other products, such as
building plaster. The drywall market in Western
Europe is projected to expand over two percent
annually through 2018 to over one billion square
meters, a rate above the 2008- 2013 pace but the
slowest globally. Many countries are expected to
post rebounds in demand as their housing markets
recover, with Spain registering the fastest
growth and Italy and the UK also forecast to
perform well.
5
The report enhances decision making capabilities
and help to create effective counter strategies
to gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.
6
Scope- The report provides brief overview of
NanoCarrier Co., Ltd. including business
description, key information and facts, and its
locations and subsidiaries- The report reviews
current pipeline of NanoCarrier Co., Ltd.s human
therapeutic division and enlists all their major
and minor projects- The report features product
description and descriptive mechanism of action
for key pipeline products along with the
products developmental history and major
milestones - Special feature on out-licensed and
partnered product portfolio- The report
summarizes all the dormant and discontinued
pipeline projects- Latest company statement -
Latest news and deals relating to the NanoCarrier
Co., Ltd.s pipeline products
7
Reasons to buy- Evaluate NanoCarrier Co.,
Ltd.s strategic position with total access to
detailed information on its product pipeline-
Assess the growth potential of NanoCarrier Co.,
Ltd. in its therapy areas of focus- Identify new
drug targets and therapeutic classes in the
NanoCarrier Co., Ltd.s RD portfolio and develop
key strategic initiatives to reinforce pipeline
in those areas- Exploit in-licensing
opportunities by identifying windows of
opportunity to fill portfolio gaps- Develop
strategic initiatives by understanding the focus
areas of NanoCarrier Co., Ltd. and exploit
collaboration and partnership opportunities
8
- Identify emerging players with potentially
strong product portfolio and create effective
counter-strategies to gain competitive
advantage- Plan mergers and acquisitions
effectively by identifying the most promising
pipeline of NanoCarrier Co., Ltd.- Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and scope- Explore the
dormant and discontinued projects of NanoCarrier
Co., Ltd. and identify potential opportunities in
those areas- Avoid Intellectual Property Rights
related issues
9
Table Of Content

• Table of Contents
• List of Tables
• List of Figures
• NanoCarrier Co., Ltd. Snapshot
• NanoCarrier Co., Ltd. Overview
• Key Information
• Key Facts
• NanoCarrier Co., Ltd. - Research and Development
  Overview
• Key Therapeutic Areas 6
• NanoCarrier Co., Ltd. - Pipeline Review
• Pipeline Products by Stage of Development

10

• For more info NanoCarrier Co., Ltd. - Product
  Pipeline Review 2014
• For Discounted Reports Kindly Click Here

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com